Background: Whether people experiencing homelessness (PEH) have different COVID-19 outcomes than housed patients in Canada remains unclear. We sought to ascertain whether rates of in-hospital ...
Outcomes for people experiencing homelessness with COVID-19 presenting to emergency departments in Canada, compared with housed patients ...
Five Things to Know About ...: Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes ...
Les agonistes du récepteur du peptide-1 de type glucagon (GLP-1) sont utilisés pour le traitement du diabète, de l’obésité, et du syndrome des ovaires polykystiques (SOPK) Le sémaglutide, le ...